TCI Wealth Advisors’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-42
Closed -$4K 2284
2022
Q1
$4K Buy
+42
New +$5.54K ﹤0.01% 1669
2021
Q4
Sell
-25
Closed -$6K 2313
2021
Q3
$6K Buy
25
+16
+178% +$4.57K ﹤0.01% 1427
2021
Q2
$4K Buy
+9
New +$3.56K ﹤0.01% 1538
2020
Q2
Sell
-1
Closed 1467
2020
Q1
$0 Hold
1
﹤0.01% 1488
2019
Q4
$1K Hold
1
﹤0.01% 1292
2019
Q3
$1K Hold
1
﹤0.01% 1233
2019
Q2
$1K Hold
1
﹤0.01% 1148
2019
Q1
$2K Hold
1
﹤0.01% 999
2018
Q4
$1K Hold
1
﹤0.01% 1156
2018
Q3
$2K Hold
1
﹤0.01% 1008
2018
Q2
$2K Hold
1
﹤0.01% 1037
2018
Q1
$2K Hold
1
﹤0.01% 941
2017
Q4
$2K Hold
1
﹤0.01% 995
2017
Q3
$2K Hold
1
﹤0.01% 933
2017
Q2
$1K Hold
1
﹤0.01% 1099
2017
Q1
$1K Hold
1
﹤0.01% 1051
2016
Q4
$1K Sell
1
-8
-89% -$6.35K ﹤0.01% 1131
2016
Q3
$8K Hold
9
﹤0.01% 626
2016
Q2
$5K Buy
9
+8
+800% +$4.53K ﹤0.01% 705
2016
Q1
$0 Hold
1
﹤0.01% 1327
2015
Q4
$1K Buy
+1
New +$999 ﹤0.01% 919

Other funds holding BLUE

TCI Wealth Advisors's BLUE Position: Q2 2022 in Review

TCI Wealth Advisors sold out of bluebird bio (BLUE) in Q2 2022, closing a stake of 42 shares — an estimated $4K sold.

TCI Wealth Advisors first reported a position in BLUE in Q4 2015 and held it in 21 quarters. The position peaked at $8K in Q3 2016. 151 funds tracked by Wall St. Rank hold BLUE as of Q2 2022.

  • TCI Wealth Advisors reported no remaining bluebird bio position as of Q2 2022 after selling out during the quarter.
  • TCI Wealth Advisors sold 42 bluebird bio shares in Q2 2022, an estimated $4K.
  • TCI Wealth Advisors first reported a position in bluebird bio in Q4 2015 and held it in 21 quarters.
  • TCI Wealth Advisors's bluebird bio position peaked at $8K in Q3 2016.
  • 151 funds tracked by Wall St. Rank held bluebird bio as of Q2 2022.

Based on TCI Wealth Advisors's 13F filing for Q2 2022, filed 19 Jul 2022.